Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
ECLINICALMEDICINE
Journal
Overview
Identity
Other
View All
Overview
publication venue for
A phase II clinical trial evaluating the safety and efficacy of durvalumab as first line therapy in advanced and metastatic non-small cell lung cancer patients with Eastern Cooperative Oncology Group performance status of 2
. 66.
2023
Clinical Transformation Through Change Management Case Study: Chest Pain in the Emergency Department
. 10:78-83.
2019
Identity
Electronic International Standard Serial Number (EISSN)
2589-5370
Other
journal abbreviation
ECLINICALMEDICINE